Skip to content

RCT study of red and purple light combined with drugs in treatment of advanced vitiligo

Clinical study on red-violet light alone or combined with ultraviolet treatment for stable vitiligo

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127822
Enrollment
Unknown
Registered
2026-07-08
Start date
2024-06-01
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitiligo

Interventions

Treatment group B:Red and purple light treatment
Treatment group A:Ultraviolet treatment

Sponsors

The Second Affiliated Hospital of Xi 'an Jiaotong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1.Age of 14-65 years old, regardless of gender; 2.Patients were diagnosed with vitiligo and met the criteria for advanced vitiligo according to the Chinese Journal of Dermatology Consensus on Vitiligo Diagnosis and Treatment (2021 edition); 3.Stable vital signs; 4.All subjects had signed the informed consent;

Exclusion criteria

Exclusion criteria: 1.Systemic treatment with investigational drugs, biological agents, and immunosuppressive agents (corticosteroids or small-molecule JAK inhibitors) within 4 weeks, topical corticosteroids, phototherapy, etc., within 2 weeks; 2.Patients with a history of serious systemic diseases or malignant tumors; 3.Pregnant women or nursing mothers; 4.Abnormal liver and kidney function (increased AST, ALT, CREA more than 2 times) or blood routine (WBC, RBC or PLT less than 80% of normal value); 5.Other conditions considered by the investigator to be inappropriate for trial participation;

Design outcomes

Primary

MeasureTime frame
Vitiligo Area Scoring Index;

Secondary

MeasureTime frame
Dermatology Life Quality Index;Patient satisfaction scores;

Countries

China

Contacts

Public ContactYumin Xia

The Second Affiliated Hospital of Xi 'an Jiaotong University

xiayumin1202@163.com+86 29 8767 8325

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026